Atul Kumar Gupta

Employment

• Pacific Institute of Medical Sciences Consultant Medical Oncologist
  2026 - Present
• Royal Marsden NHS Foundation Trust ESMO-ICF Fellow
  2026 - 2026
• All India Institute of Medical Sciences Jodhpur Senior Resident

Education

• S.M.S. Medical College M.B.B.S.
• Symbiosis International University Diploma in Medicolegal Services
• D.Y. Patil University MBA
• Symbiosis International University Diploma in Clinical Research
• All India Institute of Medical Sciences Jodhpur Doctorate of Medicine (Radiotherapy & Oncology)

Projects & Funding

Projects & funding information is unavailable.

Publications (20)

• The gut microbiome–tumor microenvironment axis in immunotherapy response: Mechanistic insights and clinical implications
  International Journal of Molecular and Immuno Oncology 2026 DOI: 10.25259/ijmio_8_2026
  +Save
• Management of myiasis in advanced head and neck cancers: a comprehensive review
  Supportive Care in Cancer 2026 DOI: 10.1007/s00520-026-10785-w
  +Save
• Coverage-Driven Obliteration and Neurocognitive Preservation Following LINAC-Based Stereotactic Radiosurgery and Fractionated Stereotactic Radiotherapy for Intracranial Arteriovenous Malformations: A Single-Institution Case Series
  Asian Journal of Neurosurgery 2026 DOI: 10.1055/s-0046-1823132
  +Save
• Malignant Fungating Wounds in Advanced Cancer: Pathophysiology, Odor Control, and Dignity-Centered Management
  Current Oncology Reports 2026 DOI: 10.1007/s11912-026-01785-4
  +Save
• Trismus management in head and neck cancer survivors: comprehensive rehabilitation-focused review
  BMJ Supportive & Palliative Care 2026 DOI: 10.1136/spcare-2026-006153
  +Save
• EORTC QLQ-BR45-based assessment of quality of life in breast cancer survivors: A comprehensive study.
  Asian Journal of Oncology 2026 DOI: 10.25259/asjo_87_2025
  +Save
• 128P Real world outcome analysis in localised Ewing’s sarcoma: Impact of tumor characteristics and multimodality therapy
  ESMO Rare Cancers 2026 DOI: 10.1016/j.esmorc.2026.100334
  +Save
• Obesity, inflammation, and cancer immunotherapy: The adipose–immune axis as a therapeutic frontier
  International Journal of Molecular and Immuno Oncology 2026 DOI: 10.25259/ijmio_35_2025
  +Save
• Metronomic chemotherapy in resource-limited settings: evidence, opportunities, and future directions
  Medical Oncology 2026 DOI: 10.1007/s12032-026-03275-w
  +Save
• Unintended coverage: How standard breast radiotherapy doses the internal mammary nodes
  Reports of Practical Oncology and Radiotherapy 2026 DOI: 10.5603/rpor.113321
  +Save